GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » EPS without NRI

Target Group (Target Group) EPS without NRI : $-0.00 (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Target Group EPS without NRI?

Target Group's earnings per share without non-recurring items for the three months ended in Mar. 2024 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.00.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 9.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 38.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Target Group's EPS without NRI or its related term are showing as below:

CBDY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 9.1   Med: 75   Max: 95.5
Current: 9.1

During the past 11 years, Target Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 95.50% per year. The lowest was 9.10% per year. And the median was 75.00% per year.

CBDY's 3-Year EPS without NRI Growth Rate is ranked worse than
50.41% of 847 companies
in the Drug Manufacturers industry
Industry Median: 9.2 vs CBDY: 9.10

Target Group's EPS (Diluted) for the three months ended in Mar. 2024 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.

Target Group's EPS (Basic) for the three months ended in Mar. 2024 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.


Target Group EPS without NRI Historical Data

The historical data trend for Target Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group EPS without NRI Chart

Target Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 - -0.01 - -

Target Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Target Group's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Target Group's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Target Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Target Group's PE Ratio without NRI falls into.



Target Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Target Group  (OTCPK:CBDY) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Target Group EPS without NRI Related Terms

Thank you for viewing the detailed overview of Target Group's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Target Group (Target Group) Business Description

Traded in Other Exchanges
N/A
Address
20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.
Executives
Barry Alan Katzman director 36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone director 564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte director 18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam director 42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali officer: CFO 134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr director, 10 percent owner, officer: President 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann director, 10 percent owner, officer: CEO 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust 10 percent owner 52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada) 10 percent owner 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr other: See Remarks 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy director, 10 percent owner, officer: president 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: vice president 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Target Group (Target Group) Headlines